Home > Journals > Minerva Biotecnologica > Past Issues > Minerva Biotecnologica 1999 December;11(4) > Minerva Biotecnologica 1999 December;11(4):325-334

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

  TUMOR IMMUNOLOGY 

Minerva Biotecnologica 1999 December;11(4):325-334

Copyright © 1999 EDIZIONI MINERVA MEDICA

language: English

Immune recognition and immunotherapy in hematological malignancies

Orsini E., Guarini A., Torelli G., Foà R.

Dipartimento di Biotecnologie Cellulari ed Ematologia, Università degli Studi di Roma “La Sapienza”, Roma; Dipartimento di Scienze Biomediche e Oncologia Umana, Università degli Studi di Torino, Torino, Italy


PDF


In the present review, we shall discuss how immunotherapy has, over the last 15 years, become a prominent part of the therapeutic armamentarium for different types of hematological malignancies. We will also focus on new prospects in rapid and promising development, as well as on possibilities of inducing immune-mediated recognition of leukemia and lymphoma cells.

top of page